Heartbeam Inc (BEAT) Stock Price, Quote & News

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recordi...

Industry: Health Information Services

Sector: Healthcare

Phone: 408 899 4443

Website: www.heartbeam.com

Address:

2118 Walsh Avenue, Suite 210, Santa Clara, United States

fiat1234 Aug. 24 at 1:46 PM

$BEAT What's this guy doing? His resume gave us hope, turning around a bunch of companies making them profitable. Drip drip drip, daily torture. HeartBeam appointed Bryan Humbarger as Chief Commercial Officer (CCO), effective January 22, 2026. Key Details: Role & Focus: In this newly created role, Humbarger was brought on to lead HeartBeam's commercial strategy and go-to-market execution.

1 · Reply

vintage84 Aug. 21 at 5:07 PM

$BEAT added some more at market. Filled at .4807 and now my avg is .5098… let’s go!!

0 · Reply

TheRoost3r Aug. 21 at 3:37 PM

$BEAT that feeling you get when your chart shows a candle that looks like you just climbed a mountain .... for .005 cents 🤣

1 · Reply

BrightStars Aug. 21 at 1:34 PM

$BEAT Best stock EVER !

1 · Reply

vintage84 Aug. 20 at 5:34 PM

$BEAT painful…. But I see good things coming 🍾🚀🍾🚀💰💰💰💰

0 · Reply

Flyhai Aug. 20 at 5:16 PM

$BEAT how do we have 2 FDA clearance and this is under $1? 🤦‍♂️

1 · Reply

Flyhai Aug. 20 at 5:16 PM

$BEAT Regulatory MilestonesDecember 2024: Received FDA 510(k) clearance for its initial 3D ECG vector collector system for arrhythmia assessment. December 2025: Secured FDA 510(k) clearance for its 12-lead ECG synthesis software after a successful appeal process. Current Status: Ongoing clinical work, such as the ALIGN-ACS pilot study, targets future clearance expansions for acute coronary syndrome (heart attack) detection.

1 · Reply

TheRoost3r Aug. 20 at 2:46 PM

$BEAT we need a new ticker name ... BEATINGS

1 · Reply

BrightStars Aug. 20 at 8:18 AM

$BEAT we need that FDA approval again. FAST !

1 · Reply

If_ur_not_first_ur_last Aug. 19 at 11:35 PM

$BTC.X $MSTR $BEAT The future!!

2 · Reply

HeartBeam reports Q2 EPS (10c) vs (15c) last year

2026-08-16T14:14:12.000Z - 8 days ago

HeartBeam sees Q3 cash flow in line with Q2

Aug 13, 2026, 4:30 PM EDT - 10 days ago

HeartBeam Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

HeartBeam Quarterly report: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

HeartBeam Slides: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 10 days ago

HeartBeam Earnings release: Q2 2026

Aug 13, 2026, 4:01 PM EDT - 10 days ago

HeartBeam Reports Second Quarter 2026 Results

Jul 31, 2026, 1:00 PM EDT - 23 days ago

HeartBeam Transcript: AGM 2026

Jul 30, 2026, 7:00 AM EDT - 25 days ago

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

2026-07-14T11:55:31.000Z - 5 weeks ago

HeartBeam initiated with a Buy at Maxim

2026-07-14T11:05:21.000Z - 5 weeks ago

HeartBeam awarded U.S. patent for ECG device capabilities

2026-06-30T11:05:24.000Z - 7 weeks ago

HeartBeam completes patient enrollment in ALIGN-ACS pilot study

Jun 30, 2026, 7:00 AM EDT - 7 weeks ago

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

Jun 25, 2026, 8:00 AM EDT - 2 months ago

HeartBeam Proxy statement: Proxy filing

2026-06-24T20:10:41.000Z - 2 months ago

HeartBeam announces strategic shift to ambulatory ECG signal platform

Jun 24, 2026, 4:05 PM EDT - 2 months ago

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

Jun 18, 2026, 8:00 AM EDT - 2 months ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 8:00 AM EDT - 2 months ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 2 months ago

HeartBeam Slides: Investor presentation

2026-06-02T11:05:34.000Z - 2 months ago

HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG

Jun 2, 2026, 7:00 AM EDT - 2 months ago

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

2026-05-22T10:10:58.000Z - 3 months ago

HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

2026-05-15T14:03:56.000Z - 3 months ago

HeartBeam price target lowered to $5 from $8 at Benchmark

May 13, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Slides: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

HeartBeam Earnings release: Q1 2026

2026-05-13T20:08:51.000Z - 3 months ago

HeartBeam reports Q1 EPS (12c) vs. (18c) last year

May 13, 2026, 4:01 PM EDT - 3 months ago

HeartBeam Reports First Quarter 2026 Results

2026-05-11T15:12:35.000Z - 3 months ago

HeartBeam initiates pilot study of first on-demand 12-lead ECG patch

May 11, 2026, 8:31 AM EDT - 3 months ago

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

2026-05-07T20:27:33.000Z - 3 months ago

HeartBeam announces commercial agreement with Atelier Health

May 7, 2026, 8:31 AM EDT - 3 months ago

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

Apr 30, 2026, 8:31 AM EDT - 4 months ago

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

2026-04-20T12:02:38.000Z - 4 months ago

HeartBeam downgraded to Hold from Buy at D. Boral Capital

Apr 16, 2026, 4:05 PM EDT - 4 months ago

HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

Apr 16, 2026, 7:00 AM EDT - 4 months ago

HeartBeam Slides: Investor presentation

2026-04-15T09:55:54.000Z - 4 months ago

HeartBeam 12.5M share Spot Secondary priced at 80c

Apr 14, 2026, 10:00 PM EDT - 4 months ago

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

2026-04-14T20:10:16.000Z - 4 months ago

HeartBeam announces common stock offering, no amount given

Apr 14, 2026, 4:05 PM EDT - 4 months ago

HeartBeam Announces Proposed Public Offering of Common Stock

2026-03-31T09:40:38.000Z - 5 months ago

HeartBeam initiated with a Buy at B. Riley

2026-03-31T09:20:14.000Z - 5 months ago

HeartBeam initiated with a Buy at Stifel

2026-03-27T12:37:18.000Z - 5 months ago

HeartBeam initiated with a Buy at D. Boral Capital

Mar 16, 2026, 11:20 AM EDT - 5 months ago

HeartBeam Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 13, 2026, 8:00 AM EDT - 5 months ago

HeartBeam Registration statement: Registration Filing

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Earnings release: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Annual report: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Slides: Q4 2025

2026-03-12T20:05:25.000Z - 5 months ago

HeartBeam reports Q4 EPS (62c) vs (73c) last year

Mar 12, 2026, 4:01 PM EDT - 5 months ago

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

Mar 12, 2026, 7:00 AM EDT - 5 months ago

HeartBeam Slides: Investor presentation

2026-03-10T11:27:46.000Z - 5 months ago

HeartBeam announces AI pact with Icahn School of Medicine at Mount Sinai

Mar 10, 2026, 7:00 AM EDT - 5 months ago

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

Mar 9, 2026, 7:00 AM EDT - 6 months ago

HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

Mar 5, 2026, 7:00 AM EST - 6 months ago

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

Mar 4, 2026, 4:01 PM EST - 6 months ago

HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

Mar 4, 2026, 7:00 AM EST - 6 months ago

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

Feb 9, 2026, 7:00 AM EST - 7 months ago

HeartBeam Registration statement: Registration Filing

Jan 22, 2026, 7:00 AM EST - 7 months ago

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Jan 5, 2026, 7:00 AM EST - 8 months ago

HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

Dec 10, 2025, 7:00 AM EST - 9 months ago

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Nov 26, 2025, 4:32 PM EST - 9 months ago

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Slides: Q3 2025

Nov 13, 2025, 4:01 PM EST - 10 months ago

HeartBeam Reports Third Quarter 2025 Results

Oct 30, 2025, 7:00 AM EDT - 10 months ago

HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time

Oct 28, 2025, 7:00 AM EDT - 10 months ago

HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere

Sep 8, 2025, 7:00 AM EDT - 1 year ago

HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

Aug 28, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Second Quarter 2025 Results

Jul 30, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

Jul 22, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

Jun 24, 2025, 2:00 PM EDT - 1 year ago

HeartBeam Transcript: IAccess Alpha Virtual Best Ideas Summer Investment Conference 2025

Jun 17, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

May 29, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q1 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 5, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 1, 2025, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

Apr 29, 2025, 8:31 AM EDT - 1 year ago

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Apr 24, 2025, 8:31 AM EDT - 1 year ago

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Annual report: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q4 2024

Mar 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 6, 2025, 9:01 AM EST - 1 year ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Feb 27, 2025, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 25, 2025, 4:01 PM EST - 1 year ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 1 year ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 1 year ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Dec 23, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 16, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Nov 19, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

HeartBeam Reports Third Quarter 2024 Results

Oct 31, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 17, 2024, 8:31 AM EDT - 2 years ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

fiat1234 Aug. 24 at 1:46 PM

1 · Reply

vintage84 Aug. 21 at 5:07 PM

$BEAT added some more at market. Filled at .4807 and now my avg is .5098… let’s go!!

0 · Reply

TheRoost3r Aug. 21 at 3:37 PM

$BEAT that feeling you get when your chart shows a candle that looks like you just climbed a mountain .... for .005 cents 🤣

1 · Reply

BrightStars Aug. 21 at 1:34 PM

$BEAT Best stock EVER !

1 · Reply

vintage84 Aug. 20 at 5:34 PM

$BEAT painful…. But I see good things coming 🍾🚀🍾🚀💰💰💰💰

0 · Reply

Flyhai Aug. 20 at 5:16 PM

$BEAT how do we have 2 FDA clearance and this is under $1? 🤦‍♂️

1 · Reply

Flyhai Aug. 20 at 5:16 PM

1 · Reply

TheRoost3r Aug. 20 at 2:46 PM

$BEAT we need a new ticker name ... BEATINGS

1 · Reply

BrightStars Aug. 20 at 8:18 AM

$BEAT we need that FDA approval again. FAST !

1 · Reply

If_ur_not_first_ur_last Aug. 19 at 11:35 PM

$BTC.X $MSTR $BEAT The future!!

2 · Reply

nhadar Aug. 19 at 9:00 PM

$BEAT sorry I was wrong we up 0.00002

0 · Reply

nhadar Aug. 19 at 4:17 PM

$BEAT closing down 100% but we star strong

0 · Reply

vintage84 Aug. 19 at 6:20 AM

$BEAT let’s see 1000% from here 🍾🚀🍾🚀💰💰💰💰

1 · Reply

nhadar Aug. 18 at 6:40 PM

$BEAT pain not gona stop til 0.25 and rs then more pain all way to bc

0 · Reply

BrightStars Aug. 18 at 3:08 PM

$BEAT please….

0 · Reply

TheRoost3r Aug. 18 at 2:31 PM

$BEAT well ...

0 · Reply

nhadar Aug. 18 at 1:59 PM

$BEAT atl like I said 0.25 then rs

0 · Reply

fiat1234 Aug. 17 at 6:37 PM

$BEAT Short Interest (% of Float): ~5.4%. About 2.54 million shares are currently sold short. This is elevated compared to average broad-market equities (~2%–3%), but well below extreme "squeeze candidate" levels (which typically sit above 20%). No wonder it'snot going anywhere, half penny up and half penny down

0 · Reply

BrightStars Aug. 17 at 3:19 PM

$BEAT It looks like they are going for the R/S because they keep diluting soooooo it looks like I’m going to be stuck with a $20.30 share price IF they do a 1/10 RS I guess I’m a lifelong holder now. 😞

1 · Reply

BrightStars Aug. 17 at 1:02 PM

$BEAT wow I have never owned a stock that is this low. I really think this stock needs to get some positive news out about the USA city sites and their progress. Just staying quiet for the next 3 months is going to put this stock at .17c …. Come on man.

1 · Reply

MadBee511 Aug. 16 at 2:38 AM

$HGRAF $BEAT

0 · Reply

Tradeforincome Aug. 15 at 3:59 PM

$BEAT should have a RS vote on the next agenda.

0 · Reply

Market Cap	27.80M
Revenue (ttm)	0.00
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	210,100
Avg Vol	755,402
Day's Range	N/A - N/A
Shares Out	56.35M
Stochastic %K	14%
Beta	-0.78
Analysts	Strong Sell
Price Target	$3.38